Nathaniel Calloway
Director/Miembro de la Junta en ANEBULO PHARMACEUTICALS, INC. .
Fortuna: 57 740 $ al 31/05/2024
Perfil
Nathaniel Calloway is currently the Director at Lifecore Biomedical, Inc., an Independent Director at Anebulo Pharmaceuticals, Inc., and a Healthcare Analyst at 22NW LP.
Previously, he worked as an Analyst at Edison Investment Research, Inc. from 2015 to 2021.
Dr. Calloway holds a graduate degree from The Trustees of Columbia University in The City of New York, a doctorate degree from Cornell University, and an undergraduate degree from The University of North Carolina at Chapel Hill (conferred in 2004).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/05/2024 | 9 887 ( 0.03% ) | 57 740 $ | 31/05/2024 |
Cargos activos de Nathaniel Calloway
| Empresas | Cargo | Inicio |
|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/11/2022 |
| LIFECORE BIOMEDICAL, INC. | Director/Miembro de la Junta | 09/01/2023 |
22NW LP
 22NW LP Investment ManagersFinance 22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle. | Analyst-Equity | 01/06/2021 |
Antiguos cargos conocidos de Nathaniel Calloway.
| Empresas | Cargo | Fin |
|---|---|---|
Edison Investment Research, Inc.
 Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Analyst-Equity | 01/06/2021 |
Formación de Nathaniel Calloway.
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Cornell University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| LIFECORE BIOMEDICAL, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Edison Investment Research, Inc.
Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Finance |
22NW LP
22NW LP Investment ManagersFinance 22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle. | Finance |
- Bolsa de valores
- Insiders
- Nathaniel Calloway
